Pilot Clinical Trial on HB01

A Randomized Pilot Clinical Study on the use of a Herbal Product, HB01, for the treatment of Adult HIV patients in Anambra State, Nigeria.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR201704001120121

Enrollment

Registered

2015-04-28

Start date

2015-05-04

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV/AIDS

Interventions

HB01

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: - Both male and female individuals. - Aged between 18-60years who are - Confirmed HIV positive patients.

Exclusion criteria

Exclusion criteria: - Refusal of consent to the study. - Pregnancy (in women). - Falling outside the age bracket (18-60years).

Design outcomes

Primary

Measure	Time frame
Viral load;CD4 count	—

Secondary

Measure	Time frame
Liver Function Test;Serum Electrolyte Concentration ;Body mass index	—

Countries

Nigeria

Contacts

Public ContactUchenna ;Uchenna Ogwaluonye ;Eleje

;

pharmuchenna@yahoo.com;georgel21@yahoo.com+2347038139755;+2348068117444

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026